Susquehanna International Group’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,000
Closed -$19.9K 13151
2025
Q4
$19.9K Sell
10,000
-6,600
-40% -$10.1K ﹤0.01% 11960
2025
Q3
$27.1K Buy
16,600
+6,000
+57% +$11.7K ﹤0.01% 11999
2025
Q2
$24.2K Sell
10,600
-1,800
-15% -$2.98K ﹤0.01% 12296
2025
Q1
$19.2K Sell
12,400
-76,700
-86% -$156K ﹤0.01% 12119
2024
Q4
$209K Buy
89,100
+76,500
+607% +$259K ﹤0.01% 10637
2024
Q3
$45.7K Sell
12,600
-4,000
-24% -$16K ﹤0.01% 11416
2024
Q2
$57.8K Sell
16,600
-43,400
-72% -$187K ﹤0.01% 11347
2024
Q1
$383K Buy
+60,000
New +$374K ﹤0.01% 9130
2022
Q1
Sell
-22,200
Closed -$115K 12961
2021
Q4
$115K Sell
22,200
-34,600
-61% -$208K ﹤0.01% 12036
2021
Q3
$372K Buy
+56,800
New +$359K ﹤0.01% 10093

Other funds holding AUTL